The evaluation of serum brain‐derived neurotrophic factor and neurofilament light chain levels in patients with obstructive sleep apnea syndrome
Open Access
- 20 October 2021
- journal article
- research article
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 6 (6), 1466-1473
- https://doi.org/10.1002/lio2.683
Abstract
Objectives This study aimed to compare serum levels of brain-derived neurotrophic factor (BDNF) and neurofilament light (NfL) chain in normal individuals and patients with mild and moderate-severe obstructive sleep apnea syndrome (OSAS). Methods We enrolled 81 subjects referred to Otorhinolaryngology (Ear-Nose-Throat), Gazi University Faculty of Medicine, between 2017 and 2019. Based on the severity of OSAS, patients were divided into three groups: group 1 with mild OSAS (apnea-hypopnea index [AHI] 5-15; n = 26), group 2 with moderate-severe OSAS (AHI > 15; n = 32), and group 3 with normal individuals (AHI scores < 5; n = 23). Results Serum NfL and BDNF levels were evaluated together with the clinical data for all subjects. Significant differences were seen in the oxygen desaturation index (ODI), apnea index, hypopnea index, sleep efficiency, and NfL levels (P < .05) between the three groups. In the moderate-severe group, NfL levels showed a significant positive correlation with apnea index (P < .05, r = .389), hypopnea index (P < .05, r = .455), and ODI (P = .04; r = .362). Conclusions Our findings clarify the pathophysiology of OSAS in cases of repetitive hypoxia and chronic neuronal damage. Based on our results, we recommend that in addition to BDNF, NfL should also be evaluated in different and larger patient cohorts.Keywords
This publication has 38 references indexed in Scilit:
- Increased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological DiseasesPLOS ONE, 2013
- Acute intermittent hypoxia-induced expression of brain-derived neurotrophic factor is disrupted in the brainstem of methyl-CpG-binding protein 2 null miceNeuroscience, 2012
- Brain-Derived Neurotrophic Factor and Neuropsychiatric DisordersPharmacological Reviews, 2012
- Chronic intermittent hypoxia-induced deficits in synaptic plasticity and neurocognitive functions: a role for brain-derived neurotrophic factorActa Pharmacologica Sinica, 2012
- Oxidative stress, inflammation, and cancer: How are they linked?Free Radical Biology & Medicine, 2010
- A simple role for BDNF in learning and memory?Frontiers in Molecular Neuroscience, 2010
- A Causal Role for Brain-Derived Neurotrophic Factor in the Homeostatic Regulation of SleepJournal of Neuroscience, 2008
- Obstructive sleep apnea syndrome and inflammationJournal of Allergy and Clinical Immunology, 2005
- Regulation of brain-derived neurotrophic factor (BDNF) during sleep apnoea treatmentThorax, 2005
- Mini ReviewGrowth Factors, 2004